News | November 23, 2023
Merck to acquire Caraway Therapeutics
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Total transaction value of the divestment is Rs. 3,660 million
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Subscribe To Our Newsletter & Stay Updated
